Psychosocial issues in pediatric inflammatory bowel disease: Report of the north american society for pediatric gastroenterology, hepatology, and nutrition

Journal of Pediatric Gastroenterology and Nutrition

Volumn 56, Issue 4, 2013, Pages 449-458

  MacKner, Laura M ^a   Greenley, Rachel Neff ^b   Szigethy, Eva ^c   Herzer, Michele ^d   Deer, Kate ^e   Hommel, Kevin A ^f  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d CHILDREN S MERCY HOSPITAL   (United States)

^e UNIVERSITY OF HARTFORD   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

family functioning; health related quality of life; psychopathology; psychosocial functioning; social functioning

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; CORTICOSTEROID; FLUOXETINE; FLUVOXAMINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ABDOMINAL PAIN; ANXIETY DISORDER; CHILD; CHILD PSYCHIATRY; COGNITIVE THERAPY; DISEASE ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DSM-IV; ENTERITIS; FAMILY; FAMILY FUNCTIONING; GENERALIZED ANXIETY DISORDER; GROUPS BY AGE; HEALTH CARE PERSONNEL; HUMAN; MAJOR DEPRESSION; MEDICAL SOCIETY; PATIENT CARE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; PSYCHOSOCIAL CARE; QUALITY OF LIFE; REVIEW; RISK FACTOR; SCHOOL HEALTH SERVICE; SCREENING; SOCIAL INTERACTION; SOCIAL PHOBIA; SOCIAL PSYCHOLOGY;

ADOLESCENT; ADOLESCENT DEVELOPMENT; CHILD; CHILD DEVELOPMENT; FAMILY; HUMANS; INFLAMMATORY BOWEL DISEASES; MENTAL DISORDERS; NORTH AMERICA; QUALITY OF LIFE; SOCIETIES, MEDICAL; SOCIETIES, SCIENTIFIC;

EID: 84875858720     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182841263     Document Type: Review

References (96)

1. Birmaher B, Brent D, Bernet W, et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 2007;46:1503-26.
2. Dulcan D. Textbook of Child and Adolescent Psychiatry. Arlington, VA: American Psychiatric Publishing, Inc; 2010.
3. Burke P, Meyer V, Kocoshis S, et al. Depression and anxiety in pediatric inflammatory bowel disease and cystic fibrosis. J Am Acad Child Adolesc Psychiatry 1989;28:948-51.
4. Szigethy E, Carpenter J, Baum E, et al. Case study: Longitudinal treatment of adolescents with depression and inflammatory bowel disease. J Amer Acad Child Adolesc Psychiatry 2006;45:369-400.
5. Reigada LC, Fisher PH, Cutler C, et al. An innovative treatment approach for children with anxiety disorders and medically unexplained somatic complaints. Cogn Behav Pract 2008;15:140-7.
6. Szigethy E, McLafferty L, Goyal A. Inflammatory bowel disease. Child Adolesc Psychiatr Clin N Am 2010;19:301-18.
7. Engstrom I. Mental health and psychological functioning in children and adolescents with inflammatory bowel disease: a comparison with children having other chronic illnesses and with healthy children. J Child Psychol and Psychiatr 1992;33:563-82.
8. Szigethy E, Levy-Warren A, Whitton S, et al. Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J Pediatr Gastroenterol Nutr 2004;39:395-403.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: Author; 1994.
10. Engstrom I, Lindquist BL. Inflammatory bowel disease in children and adolescents: a somatic and psychiatric investigation. Acta Paediatr Scand 1991;80:640-7.
11. Mackner LM, Crandall WV, Szigethy EM. Psychosocial functioning in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006;12: 239-44.
12. Greenley RN, Hommel KA, Nebel J, et al. A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. J Pediatr Psychol 2010;35:857-69.
13. Mittermaier C, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 2004;66:79-84.
14. Zimmerman L, Srinath A, Nurko S, et al. Characterization of functional abdominal pain in pediatric Crohn's disease. Gastroenterology 2010;140 (suppl 1):S510.
15. Mrakotsky C, Bousvaros A, Chriki L, et al. Impact of acute steroid treatment on memory, executive function, and mood in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2005;42: 540-1.
16. Benhayon D, Binion D, Regueiro M, et al. Characterization of sleep in a pediatric population with inflammatory bowel disease and depression. Gastroenterology 2011;140 (suppl 1):S506-7.
17. Faure C, Giguère L. Functional gastrointestinal disorders and visceral hypersensitivity in children and adolescents suffering from Crohn's disease. Inflamm Bowel Dis 2008;14:1569-74.
18. Coates MD, Johnson AC, Greenwood-Van Meerveld B, et al. Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse. Neurogastroenterol Motil 2006;18: 464-71.
19. Wolf AM, Wolf D, Rumpold H, et al. Overexpression of indoleamine 2, 3-dioxygenase in human inflammatory bowel disease. Clin Immunol 2004;113:47-55.
20. Compton SN, March JS, Brent D, et al. Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. J Am Acad Child Adolesc Psychiatry 2004;43:930-59.
21. Szigethy E, Whitton SW, Levy-Warren A, et al. Cognitive-behavioral therapy for depression in adolescents with inflammatory bowel disease: a pilot study. J Am Acad Child Adolesc Psychiatry 2004;43:1469-77.
22. Szigethy E, Kenney E, Carpenter J, et al. Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry 2007;46:1290-8.
23. Szigethy E, Hardy D, Craig AE, et al. Girls connect: effects of a support group for teenage girls with inflammatory bowel disease and their mothers. Inflamm Bowel Dis 2009;15:1127-8.
24. Mufson L, Weissman MM, Moreau D, et al. Efficacy of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry 1999;56:573-9.
25. Shaoul R, Sukhotnik I, Mogilner J. Hypnosis as an adjuvant treatment for children with inflammatory bowel disease. J Dev Behav Pediatr 2009;30:268.
26. Emslie GJ, Rush AJ, Weinberg WA, K et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997;54:1031-7.
27. Emslie GJ, Kennard BD, Mayes TL, et al. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry 2008;165:459-67.
28. Wagner KD, Ambrosini P, Rynn M, et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA 2003;290: 1033-41.
29. March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 2004;292:807-20.
30. Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med 2008;359:2753-66.
31. Ryan ND. Psychoneuroendocrinology of children and adolescents. Psychiatr Clin North Am 1998;21:435-41.
32. March JS, Entusah AR, Rynn M, et al. A randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. Biol Psychiatry 2007;62:1149-54.
33. Campo JV, Perel J, Lucas A, et al. Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: an exploratory study. J Am Acad Child Adolesc Psychiatry 2004;43: 1234-42.
34. Kovacs M. Children's Depression Inventory Manual. North Tonawanda, NY: Multi-Health Systems, Inc; 1992.
35. Foley KF, Pantano C, Ciolino A, et al. IFN-gamma and TNF-alpha decrease serotonin transporter function and expression in Caco2 cells. Am J Physiol Gastrointest Liver Physiol 2007;292:G779-84.
36. Drotar D LR, Plaermo TM, et al. Clinical applications of health related quality of life assessment for children and adolescents. In: Drotar D, ed. Measuring Health-related Quality of Life in Children and Adolescents: Implications for Research and Practice. Mahwah, NJ: Lawrence Erl-baum; 1998:329-39.
37. Eiser C. Social support in chronically sick children and their families. In: Nestman F, Hurrelmann K, eds. Social Networks and Social Support in Childhood and Adolescence. New York: Walter de Gruyter; 1994: 347-59.
38. Quittner A, Davis M, Modi A. Health-related quality of life in pediatric populations. In: Roberts MC, ed. Handbook of Pediatric Psychology. New York: Guilford; 2003:696-709.
39. Palermo TM, Long AC, Lewandowski AS, et al. Evidence-based assessment of health-related quality of life and functional impairment in pediatric psychology. J Pediatr Psychol 2008;33:983-96.
40. Matza LS, Swensen AR, Flood EM, et al. Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues. Value Health 2004;7:79-92.
41. Riley AW. Evidence that school-age children can self-report on their health. Ambul Pediatr 2004;4 (4 suppl):371-6.
42. Griffiths A, Nicholas D, Smith C, et al. Development of a quality-of-life index for pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006;12:684-91.
43. Otley A, Smith C, Nicholas D, et al. The IMPACT questionnaire: Avalid measure of health-related quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002;35:557-63.
44. Otley A. Measurement of quality of life in pediatric inflammatory bowel disease. In: Mamula P, Baldassano R, Markowitz J, eds. Pediatric Inflammatory Bowel Disease. New York: Springer; 2008:565-76.
45. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001;39:800-12.
46. Varni JW, Burwinkle TM, Seid M, et al. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr 2003;3:329-41.
47. Kunz JH, Hommel KA, Greenley RN. Health-related quality of life of youth with inflammatory bowel disease: a comparison with published data using the PedsQL 4.0 generic core scales. Inflamm Bowel Dis 2010;16:939-46.
48. Otley AR, Griffiths AM, Hale S, et al. Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006;12:684-91.
49. Loonen HJ, Grootenhuis MA, Last BF, et al. Quality of life in paediatric inflammatory bowel disease measured by a generic and a disease-specific questionnaire. Acta Paediatr 2002;91:348-54.
50. van der Zaag-Loonen HJ, Grootenhuis MA, Last BF, et al. Coping strategies and quality of life of adolescents with inflammatory bowel disease. Qual Life Res 2004;13:1011-9.
51. Herzer M, Denson LA, Baldassano RN, et al. Family functioning and health-related quality of life in adolescents with pediatric inflammatory bowel disease. Eur J Gastroenterol Hepatol 2011;23:95-100.
52. Perrin JM, Kuhlthau K, Chughtai A, et al. Measuring quality of life in pediatric patients with inflammatory bowel disease: psychometric and clinical characteristics. J Pediatr Gastroenterol Nutr 2008;46: 164-71.
53. Marcus SB, Strople JA, Neighbors K, et al. Fatigue and health-related quality of life in pediatric inflammatory bowel disease. Clin Gastro-enterol Hepatol 2009;7:554-61.
54. Cunningham C, Drotar D, Palermo T, et al. Health-related quality of life in children and adolescents with inflammatory bowel disease. Child Healthcare 2007;36:29-43.
55. De Boer M, Grootenhuis M, Derkx B, et al. Health-related quality of life and psychosocial functioning of adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2005;11:400-6.
56. Drotar D. Relating parent and family functioning to the psychological adjustment of children with chronic health conditions: what have we learned? What do we need to know? J Pediatr Psychol 1997; 22:149-65.
57. MacPhee M, Hoffenberg EJ, Feranchak A. Quality-of-life factors in adolescent inflammatory bowel disease. Inflamm Bowel Dis 1998;4:6-11.
58. Kennedy A, Nelson E, Reeves D, et al. A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease. Gut 2004;53:1639-45.
59. García-Vega E, Fernandez-Rodriguez C. A stress management programme for Crohn's disease. Behav Res Ther 2004;42:367-83.
60. von Wietersheim J, Kessler H. Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm Bowel Dis 2006;12: 1175-84.
61. Jantschek G, Zeitz M, Pritsch M, et al. Effect of psychotherapy on the course of Crohn's disease. Results of the German prospective multi-center psychotherapy treatment study on Crohn's disease. German Study Group on Psychosocial Intervention in Crohn's Disease. Scand J Gastroenterol 1998;33:1289-96.
62. Gest SD, Sesma A Jr, Masten AS, et al. Childhood peer reputation as a predictor of competence and symptoms 10 years later. J Abnorm Child Psychol 2006;34:509-26.
63. Parker JG, Asher SR. Peer relations and later personal adjustment: are low-accepted children at risk? Psychol Bull 1987;102:357-89.
64. Cavell TA. Social adjustment, social performance, and social skills: A tri-component model of social competence. J Clin Child Psychol 1990;19:111-22.
65. Mackner LM, Crandall WV. Long-term psychosocial outcomes reported by children and adolescents with inflammatory bowel disease. Am J Gastroenterol 2005;100:1386-92.
66. Mackner LM, Crandall WV. Brief report: Psychosocial adjustment in adolescents with inflammatory bowel disease. J Pediatr Psychol 2006;31:281-5.
67. Mackner LM, Vannatta K, Crandall WV. Gender differences in the social functioning of adolescents with inflammatory bowel disease. J Clin Psychol Med Settings 2012;19:270-6.
68. Shepanski MA, Hurd LB, Culton K, et al. Health-related quality of life improves in children and adolescents with Inflammatory Bowel Disease after attending a camp sponsored by the Crohn's and Colitis Foundation of America. Inflamm Bowel Dis 2005;11:164-70.
69. Engstrom I. Inflammatory bowel disease in children and adolescents: Mental health and family functioning. J Pediatr Gastroenterol Nutr 1999;28:S28-33.
70. Tojek TM, Lumley MA, Corlis M, et al. Maternal correlates of health status in adolescents with inflammatory bowel disease. J Psychosom Res 2002;52:173-9.
71. Grey M, Boland EA, Yu C, et al. Personal and family factors associated with quality of life in adolescents with diabetes. Diabetes Care 1998;21:909-14.
72. Hanson CL, De Guire MJ, Schinkel AM, et al. Comparing social learning and family systems correlates of adaptation in youths with IDDM. J Pediatr Psychol 1992;17:555-72.
73. Whittemore R, Kanner S, Singleton S, et al. Correlates of depressive symptoms in adolescents with type 1 diabetes. Pediatr Diabetes 2002; 3:135-43.
74. Anderson BJ, Brackett J, Ho J, et al. An office-based intervention to maintain parent-adolescent teamwork in diabetes management. Impact on parent involvement, family conflict, and subsequent glycemic control. Diabetes Care 1999;22:713-21.
75. Wysocki T, Harris MA, Buckloh LM, et al. Randomized, controlled trial of Behavioral Family Systems Therapy for Diabetes: maintenance and generalization of effects on parent-adolescent communication. Behav Ther 2008;39:33-46.
76. Thompson RJ, Gustafson KE, Hamlett KW, et al. Psychological adjustment of children with cystic fibrosis: the role of child cognitive processes and maternal adjustment. J Pediatr Psychol 1992;17: 741-55.
77. Engström I. Parental distress and social interaction in families with children with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 1991;30:904-12.
78. Burke PM, KocoshisS, Neigut D, et al. Maternal psychiatric disorders in pediatric inflammatory bowel disease and cystic fibrosis. Child Psychiatry Hum Dev 1994;25:45-52.
79. Engstrom I. Parental distress and social interaction in families with children with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 1991;30:904-12.
80. Speechley KN, Noh S. Surviving childhood cancer, social support, and parents' psychological adjustment. J Pediatr Psychol 1992;17:15-31.
81. Hoekstra-Weebers JE, Jaspers JP, Kamps WA, et al. Psychological adaptation and social support of parents of pediatric cancer patients: a prospective longitudinal study. J Pediatr Psychol 2001;26: 225-35.
82. Engstrom I. Psychological problems in siblings of children and adolescents with inflammatory bowel disease. Eur Child Adolsc Psychiatry 1992;1:24-33.
83. Akobeng AK, Miller V, Firth D, et al. Quality of life of parents and siblings of children with inflammatory bowel disease. J Pediatr Gastro-enterol Nutr 1999;28:S40-2.
84. Moody G, Eaden JA, Mayberry JF. Social implications of childhood Crohn's disease. J Pediatr Gastroentrol Nutr 1999;28:S43-5.
85. Rabbett H, Elbadri A, Thwaites R, et al. Quality of life in children with Crohn's disease. J Pediatr Gastroenterol Nutr 1996;23:S28-33.
86. Ferguson A, Sedgwick DM, Drummond J. Morbidity of juvenile onset inflammatory bowel disease: Effects on education and employment in early adult life. Gut 1994;35:665-8.
87. Bernstein CN, Kraut A, Blanchard JF, et al. The relationship between inflammatory bowel disease and socioeconomic variables. Am J Gas-troenterol 2001;96:2117-25.
88. Longobardi T, Jacobs P, Wu L, et al. Work losses related to inflammatory bowel disease in Canada: results from a National Population Health Survey. Am J Gastroenterol 2003;98:844-9.
89. Marri SR, Buchman AL. The education and employment status of patients with inflammatory bowel diseases. Inflamm Bowel Dis 2005; 11:171-7.
90. Calsbeek H, Rijken M, Bekkers MJ, et al. Social position of adolescents with chronic digestive disorders. Eur J Gastroenterol Hepatol 2002;14:543-9.
91. Adler J, Raju S, Beveridge AS, et al. College adjustment in University of Michigan students with Crohn's and colitis. Inflamm Bowel Dis 2008; 14:1281-6.
92. Thayu M, Mamula P. Treatment of iron deficiency anemia in pediatric inflammatory bowel disease. Curr Treat Options Gastroenterol 2005; 8:411-7.
93. Bryan J, Osendarp S, Hughes D, et al. Nutrients for cognitive development in school-aged children. Nutr Rev 2004;62:295-306.
94. Hollerbach S, Kullman F, Geissler A, et al. Impairment of short term memory functioning and morphological brain abnormalities in inflammatory bowel disease. Gastroenterology 2000;118: A313.
95. Attree EA, Dancey CP, Keeling D, et al. Cognitive function in people with chronic illness: inflammatory bowel disease and irritable bowel syndrome. Appl Neuropsychol 2003;10:96-104.
96. Dancey CP, Attree EA, Stuart G, et al. Words fail me: the verbal IQ deficit in inflammatory bowel disease and irritable bowel syndrome. Inflamm Bowel Dis 2009;15:852-7.